Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4470361
Max Phase: Preclinical
Molecular Formula: C21H17N5O4
Molecular Weight: 403.40
Molecule Type: Unknown
Associated Items:
ID: ALA4470361
Max Phase: Preclinical
Molecular Formula: C21H17N5O4
Molecular Weight: 403.40
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Nc1nc2[nH]cc(Cc3ccc(C(=O)Nc4cccc(C(=O)O)c4)cc3)c2c(=O)[nH]1
Standard InChI: InChI=1S/C21H17N5O4/c22-21-25-17-16(19(28)26-21)14(10-23-17)8-11-4-6-12(7-5-11)18(27)24-15-3-1-2-13(9-15)20(29)30/h1-7,9-10H,8H2,(H,24,27)(H,29,30)(H4,22,23,25,26,28)
Standard InChI Key: JNRSKWXVEYVQFX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 403.40 | Molecular Weight (Monoisotopic): 403.1281 | AlogP: 2.37 | #Rotatable Bonds: 5 |
Polar Surface Area: 153.96 | Molecular Species: ACID | HBA: 5 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 3.93 | CX Basic pKa: 2.38 | CX LogP: 2.37 | CX LogD: -0.70 |
Aromatic Rings: 4 | Heavy Atoms: 30 | QED Weighted: 0.34 | Np Likeness Score: -0.64 |
1. Czyzyk DJ, Valhondo M, Deiana L, Tirado-Rives J, Jorgensen WL, Anderson KS.. (2019) Structure activity relationship towards design of cryptosporidium specific thymidylate synthase inhibitors., 183 [PMID:31536894] [10.1016/j.ejmech.2019.111673] |
Source(1):